Asymptomatic ocular candida: a case outside the guidance

Introduction: Candidaemia carries a high mortality rate among inpatients.1 Deep-seated infection needs to be ruled out to guide both source control and treatment duration.2 Ophthalmic candida can lead to sight-threatening endophthalmitis, although guidelines in both the UK and USA are conflicting as...

Full description

Saved in:
Bibliographic Details
Main Authors: Roshnee Patel, Lena Wragg, Jas Virdee
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Clinical Medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S147021182500082X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849713594662387712
author Roshnee Patel
Lena Wragg
Jas Virdee
author_facet Roshnee Patel
Lena Wragg
Jas Virdee
author_sort Roshnee Patel
collection DOAJ
description Introduction: Candidaemia carries a high mortality rate among inpatients.1 Deep-seated infection needs to be ruled out to guide both source control and treatment duration.2 Ophthalmic candida can lead to sight-threatening endophthalmitis, although guidelines in both the UK and USA are conflicting as to whether patients with candidaemia but no visual symptoms should be screened for this.3–5 We present a case of a patient who developed candidaemia and was found to have chorioretinitis on routine ophthalmic examination in the absence of any visual symptoms. Materials and Methods: A 76-year-old man was admitted under the medical team with reduced consciousness after a 3-day history of fever, diarrhoea and vomiting. He had type 2 diabetes mellitus with recent surgery on a Charcot foot and a long-term urethral catheter.He was septic on admission with accompanying acute kidney injury. The initial working diagnosis was a catheter-associated urinary tract infection, and the patient started intravenous antibiotics.The patient subsequently grew both group B Streptococcus and Candida albicans in his blood cultures and antimicrobials were accordingly adjusted. Initial investigations into the source of the Candida, such as in the urinary tract, were negative and there was also no evidence of clear deep-seated infection.The microbiology team also suggested an ophthalmology review, despite the patient lacking any visual symptoms or signs.The patient was found to have bilateral chorioretinitis suggestive of ocular candidiasis, requiring a prolonged course of initially intravenous then oral fluconazole. Three weeks after he completed his anti-fungal course, a follow-up ophthalmology review reported that the chorioretinal lesions had resolved and an associated intraretinal haemorrhage was resolving. Results and Discussion: Candida bloodstream infection is increasing in incidence yearly in the UK.6 Candidaemia with evidence of ocular involvement requires at least 1 month of specific anti-fungal agents given the varying tissue penetrance of these drugs.5The Royal College of Ophthalmologists (RCOphth) argue that ophthalmic screening in visually asymptomatic patients is unnecessary because of the low overall prevalence of significant fungal eye disease requiring intervention.4 The Infectious Diseases Society of America suggests that all patients with systemic candidiasis should undergo ophthalmic screening on starting treatment.5 Our case calls into question advice from the RCOphth. The main benefit of early detection and, therefore, treatment of ocular Candida is sight preservation for the affected patient, while also providing evidence of deep-seated infection warranting extended treatment, although the relationship between the severity of chorioretinitis and progression to endophthalmitis is yet to be established.3 Conclusion: Ultimately, a core skill of our job as clinicians is risk assessment: here, assessing the risk and likelihood of severe infection versus the cost of multiple investigations and side-effects of complex drugs. Our patient was investigated outside of RCOphth guidance for candidaemia, and yet he was found to have a deep-seated infection, which ultimately improved with targeted therapy. Guidelines exist to support our decision-making, but we must ensure that we retain our clinical curiosity and tailor our strategy to the patient in front of us.
format Article
id doaj-art-2e4aa7e1a5d24aa6a6af937eb9e755d9
institution DOAJ
issn 1470-2118
language English
publishDate 2025-07-01
publisher Elsevier
record_format Article
series Clinical Medicine
spelling doaj-art-2e4aa7e1a5d24aa6a6af937eb9e755d92025-08-20T03:13:55ZengElsevierClinical Medicine1470-21182025-07-0125410036410.1016/j.clinme.2025.100364Asymptomatic ocular candida: a case outside the guidanceRoshnee Patel0Lena Wragg1Jas Virdee2The Royal Marsden, The Royal Marsden NHS Foundation TrustCroydon University Hospital, Croydon Health Services NHS TrustCroydon University Hospital, Croydon Health Services NHS TrustIntroduction: Candidaemia carries a high mortality rate among inpatients.1 Deep-seated infection needs to be ruled out to guide both source control and treatment duration.2 Ophthalmic candida can lead to sight-threatening endophthalmitis, although guidelines in both the UK and USA are conflicting as to whether patients with candidaemia but no visual symptoms should be screened for this.3–5 We present a case of a patient who developed candidaemia and was found to have chorioretinitis on routine ophthalmic examination in the absence of any visual symptoms. Materials and Methods: A 76-year-old man was admitted under the medical team with reduced consciousness after a 3-day history of fever, diarrhoea and vomiting. He had type 2 diabetes mellitus with recent surgery on a Charcot foot and a long-term urethral catheter.He was septic on admission with accompanying acute kidney injury. The initial working diagnosis was a catheter-associated urinary tract infection, and the patient started intravenous antibiotics.The patient subsequently grew both group B Streptococcus and Candida albicans in his blood cultures and antimicrobials were accordingly adjusted. Initial investigations into the source of the Candida, such as in the urinary tract, were negative and there was also no evidence of clear deep-seated infection.The microbiology team also suggested an ophthalmology review, despite the patient lacking any visual symptoms or signs.The patient was found to have bilateral chorioretinitis suggestive of ocular candidiasis, requiring a prolonged course of initially intravenous then oral fluconazole. Three weeks after he completed his anti-fungal course, a follow-up ophthalmology review reported that the chorioretinal lesions had resolved and an associated intraretinal haemorrhage was resolving. Results and Discussion: Candida bloodstream infection is increasing in incidence yearly in the UK.6 Candidaemia with evidence of ocular involvement requires at least 1 month of specific anti-fungal agents given the varying tissue penetrance of these drugs.5The Royal College of Ophthalmologists (RCOphth) argue that ophthalmic screening in visually asymptomatic patients is unnecessary because of the low overall prevalence of significant fungal eye disease requiring intervention.4 The Infectious Diseases Society of America suggests that all patients with systemic candidiasis should undergo ophthalmic screening on starting treatment.5 Our case calls into question advice from the RCOphth. The main benefit of early detection and, therefore, treatment of ocular Candida is sight preservation for the affected patient, while also providing evidence of deep-seated infection warranting extended treatment, although the relationship between the severity of chorioretinitis and progression to endophthalmitis is yet to be established.3 Conclusion: Ultimately, a core skill of our job as clinicians is risk assessment: here, assessing the risk and likelihood of severe infection versus the cost of multiple investigations and side-effects of complex drugs. Our patient was investigated outside of RCOphth guidance for candidaemia, and yet he was found to have a deep-seated infection, which ultimately improved with targeted therapy. Guidelines exist to support our decision-making, but we must ensure that we retain our clinical curiosity and tailor our strategy to the patient in front of us.http://www.sciencedirect.com/science/article/pii/S147021182500082X
spellingShingle Roshnee Patel
Lena Wragg
Jas Virdee
Asymptomatic ocular candida: a case outside the guidance
Clinical Medicine
title Asymptomatic ocular candida: a case outside the guidance
title_full Asymptomatic ocular candida: a case outside the guidance
title_fullStr Asymptomatic ocular candida: a case outside the guidance
title_full_unstemmed Asymptomatic ocular candida: a case outside the guidance
title_short Asymptomatic ocular candida: a case outside the guidance
title_sort asymptomatic ocular candida a case outside the guidance
url http://www.sciencedirect.com/science/article/pii/S147021182500082X
work_keys_str_mv AT roshneepatel asymptomaticocularcandidaacaseoutsidetheguidance
AT lenawragg asymptomaticocularcandidaacaseoutsidetheguidance
AT jasvirdee asymptomaticocularcandidaacaseoutsidetheguidance